MediciNova, Inc.
General ticker "MNOV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $75.6M (TTM average)
MediciNova, Inc. does not follow the US Stock Market performance with the rate: -5.5%.
Estimated limits based on current volatility of 2.5%: low 1.46$, high 1.52$
Factors to consider:
- Total employees count: 13 as of 2024
- Top business risk factors: Operating losses, Clinical trial failures, Third-party risks, Manufacturing risks, Sales and marketing challenges
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.51$, 3.16$]
- 2025-12-31 to 2026-12-31 estimated range: [1.35$, 2.86$]
Financial Metrics affecting the MNOV estimates:
- Positive: with PPE of -9.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.33 <= 0.33
- Positive: Shareholder equity ratio, % of 93.96 > 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: negative Net income
Short-term MNOV quotes
Long-term MNOV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $1.00MM | $0.00MM |
| Operating Expenses | $14.63MM | $10.90MM | $12.68MM |
| Operating Income | $-14.63MM | $-9.90MM | $-12.68MM |
| Non-Operating Income | $0.56MM | $1.33MM | $1.63MM |
| R&D Expense | $9.14MM | $5.66MM | $7.19MM |
| Income(Loss) | $-14.07MM | $-8.57MM | $-11.04MM |
| Taxes | $0.00MM | $0.00MM | $0.01MM |
| Profit(Loss)* | $-14.07MM | $-8.57MM | $-11.05MM |
| Stockholders Equity | $70.24MM | $62.38MM | $52.50MM |
| Assets | $74.15MM | $66.27MM | $55.88MM |
| Operating Cash Flow | $-12.91MM | $-7.43MM | $-10.64MM |
| Capital expenditure | $0.01MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $-40.01MM | $39.91MM | $-0.00MM |
| Financing Cash Flow | $0.01MM | $0.02MM | $0.00MM |
| Earnings Per Share** | $-0.29 | $-0.17 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.